|
SPORE in Pancreatic Cancer
|
5P20CA101936-05
|
$1,042,511
|
$1,042,511
|
ABBRUZZESE, JAMES
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-09
|
$645,635
|
$32,282
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
A PILOT INVESTIGATION OF ETHNIC DISPARITIES IN PATIENT-INITIATED PREMATURE TREATM
|
1R03CA128470-01
|
$72,000
|
$72,000
|
Adams, Swann
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
HOWARD UNIVERSITY CANCER CENTER/JOHNS HOPKINS CANCER CENTER PARTNERSHIP
|
5U54CA091431-07
|
$1,410,542
|
$282,108
|
ADAMS-CAMPBELL, LUCILE
|
HOWARD UNIVERSITY
|
|
MMC and VICC: Partners in Eliminating Cancer Disparities
|
5U54CA091408-07
|
$1,882,399
|
$564,720
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
Functional analysis of signaling to and from p53 in ca
|
5R01CA098916-06
|
$258,227
|
$64,557
|
AGARWAL, Munna
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Colon Cancer Chemoprevention by Flavonoid Silibinin
|
5R01CA112304-03
|
$284,889
|
$284,889
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
Clinical study of GMCI in Pancreatic Cancer
|
5R43CA119847-02
|
$376,666
|
$376,666
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
APC Tumor Suppressor in Cell Differentiation and Death
|
5R01CA105038-03
|
$239,551
|
$239,551
|
Ahmed, Yasmath
|
DARTMOUTH COLLEGE
|
|
Promoting Colon Cancer Screening in High-Risk Families
|
5R01CA068099-09
|
$453,750
|
$453,750
|
AHNEN, DENNIS
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
Dual-Spectrometer OCT for Noninvasive Imaging of Intestinal Cancers
|
1R43CA125918-01A1
|
$64,425
|
$64,425
|
Ai, Jun
|
LUMINIT, LLC
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-04
|
$234,166
|
$25,758
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Epidemiologic Studies of Techa River Cohorts
|
N01CP045505-000
|
$102,671
|
$10,267
|
AKLEYEV, ALEXANDER
|
Urals Research Center for Radiation Mede
|
|
Studies of Alpha-tocopherol and Beta-Carotene in Finland
|
Z01 CP010195
|
$742,362
|
$31,975
|
Albanes
|
DCEG (NCI)
|
|
CNP for Older Underserved African American Adults
|
3U01CA114583-03S1
|
$64,761
|
$16,190
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
CNP for Older Underserved African American Adults
|
5U01CA114583-03
|
$471,027
|
$117,757
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Blood Flow MRI for Monitoring of Renal Cell Carcinoma
|
5R21CA121570-02
|
$292,999
|
$73,250
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Molecular targeting of the survivin pathway in cancer
|
5R01CA090917-08
|
$288,775
|
$14,439
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Prediction and assessment of response to targated therapy in pancreatic cancer
|
7R21CA123888-02
|
$224,748
|
$224,748
|
ALTIOK, SONER
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Dietary Prevention of Cancer
|
5R01CA109269-04
|
$263,847
|
$263,847
|
ANANT, SHRIKANT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Santa Rosa Memorial Hospital Regional CCOP
|
3U10CA063850-12S2
|
$131,400
|
$23,652
|
ANDERSON, IAN
|
SANTA ROSA MEMORIAL HOSPITAL
|
|
Children's Oncology Group Statistics and Data Center
|
5U10CA098413-05
|
$5,859,839
|
$175,795
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Descriptive Studies and Record Linkage
|
Z01 CP010183
|
$674,691
|
$29,131
|
Anderson
|
DCEG (NCI)
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENING
|
N01CN025516-085
|
$1,656,966
|
$414,242
|
ANDRIOLE, GERALD
|
THE WASHINGTON UNIVERSITY
|
|
Extension of Radiotherapy Research
|
5P01CA006294-43
|
$1,506,020
|
$225,903
|
ANG, K
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Hereditary Breast Cancer: Genetic and Molecular Studies
|
5R01CA058860-13
|
$608,350
|
$60,835
|
ANTON-CULVER, HODA
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
African American Men Prostate & Colorectal Cancer Belief
|
5R21CA113943-02
|
$125,532
|
$62,766
|
ARCURY, THOMAS
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Reversal of 5-FU Resistance by Arsenic Trioxide in Colorectal Carcinoma
|
1R21CA117116-01A2
|
$290,541
|
$290,541
|
ARDALAN, BACH
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER
|
3R01CA102681-05S1
|
$82,880
|
$82,880
|
ASHKTORAB, HASSAN
|
HOWARD UNIVERSITY
|
|
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER
|
5R01CA102681-05
|
$251,476
|
$251,476
|
ASHKTORAB, HASSAN
|
HOWARD UNIVERSITY
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-09
|
$128,678
|
$14,155
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Southeast Cancer Control Consortium, Inc
|
3U10CA045808-21S1
|
$170,000
|
$28,900
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-21
|
$1,860,642
|
$316,309
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
FATTY ACID MODULATION OF COLON CELL TRANSFORMATION
|
1R21CA123473-01A1
|
$137,397
|
$137,397
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
Nutritional mechanisms and intestinal tumorigenesis
|
5R01CA114265-03
|
$248,050
|
$248,050
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
MOLECULAR-NUTRIENT INTERACTIONS IN INTESTINAL CANCER
|
5U54CA100926-05
|
$2,022,594
|
$2,022,594
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-33
|
$413,938
|
$45,533
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Protooncogenes-Signaling in Development and Neoplasia
|
5P01CA023767-28
|
$1,066,134
|
$266,534
|
AXEL, RICHARD
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Care Outcomes Research & Surveillance Consortium
|
3U01CA093324-05S4
|
$47,445
|
$23,723
|
AYANIAN, JOHN
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Improving Systems for Colorectal Cancer Screening
|
5R01CA112367-03
|
$477,669
|
$477,669
|
AYANIAN, JOHN
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Oxidative Pentose Cycle in Hypoxic Cancer Cell Response
|
5R01CA109604-04
|
$247,193
|
$81,574
|
AYENE, IRAIMOUDI
|
LANKENAU INSTITUTE FOR MEDICAL RESEARCH
|
|
Transcriptional control in the genesis of pancreatic intraepithelial neoplasia
|
1R21CA127822-01
|
$149,500
|
$149,500
|
Ayer, Donald
|
UNIVERSITY OF UTAH
|
|
Molecular Targeted Imaging in Colon Cancer
|
1R43CA132528-01
|
$162,918
|
$162,918
|
Backer, Joseph
|
SIBTECH, INC.
|
|
Optically Monitoring Colon Microcirculation in Precancer
|
1R01CA118794-01A2
|
$266,646
|
$266,646
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Towards Colonscopy-free Colon Cancer Screening by Enhanced Light Backscattering
|
4R33CA122017-02
|
$274,979
|
$274,979
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Spectroscopy of blood supply changes in early precancer
|
5R01CA109861-03
|
$175,501
|
$175,501
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Spectroscopic Markers to Risk-Stratify Colonic Neoplasia
|
5R01CA112315-03
|
$170,197
|
$170,197
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
PPAR-gamma ligands in colorectal cancer
|
5R01CA108975-02
|
$199,929
|
$199,929
|
BAEK, SEUNG
|
UNIVERSITY OF TENNESSEE KNOXVILLE
|
|
SAN JUAN MB COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA052667-17
|
$484,826
|
$96,965
|
BAEZ, LUIS
|
SAN JUAN CITY HOSPITAL
|
|
PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
|
N01CN035153-008
|
$1,058,141
|
$105,814
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN SYSTEM
|
Total relevant funding to Digestive Diseases for this search: $395,478,678
|